510(k) · Cleared
ClearedtransGlide Expandable Introducer
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Transaortic Medical, Inc. · DYB Introducer, Catheter
Cleared on Apr 7, 2016 as substantially equivalent to K100819 (Onset Medical Corporation, 2010) after a 246-day review. Its family tree reaches back 2 generations to 2009. 2 of the 4 devices in its family, counting itself, have a Class I recall. 1 later device descends from it.
- Decided
- Apr 7, 2016
- Review
- 246 days
- Class
- Class II
- Product code
- DYB
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K092014 (2009). 1 later device descends from it, 1 citing it directly. 2 of the 4 devices in this family, counting this one, have a Class I recall.
- Root · 2 generations backK092014 Solopath Balloon Expandable Transfemoral IntroducerOnset Medical Corporation · 2009
- 1 generation backK100819 The Solopath Balloon Expandable Transfemoral IntroducerOnset Medical Corporation · 2010 · Recalled (Class I)
- This deviceK152194 transGlide Expandable IntroducerTransaortic Medical, Inc. · 2016
- Descendant · cites it directly · 0 of its ownK181817 transGlideXT Expandable IntroducerTransaortic Medical, Inc. · 2019 · Recalled (Class I)
Class I recalls in this family
Most influential descendants
Showing 1 of 1 · See all- K181817transGlideXT Expandable IntroducerTransaortic Medical, Inc. · 2019 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K092014 | Solopath Balloon Expandable Transfemoral Introducer | Onset Medical Corporation | 2009 | — |
| −1 | K100819 | The Solopath Balloon Expandable Transfemoral Introducer | Onset Medical Corporation | 2010 | Class I |
| 0 (this device) | K152194 | transGlide Expandable Introducer | Transaortic Medical, Inc. | 2016 | — |
| +1 | K181817 | transGlideXT Expandable Introducer | Transaortic Medical, Inc. | 2019 | Class I |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2019 | 1 | 1 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DYB device
- #1 K251051 AuST Steerable Sheathscore 18.0 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K100819 | The Solopath Balloon Expandable Transfemoral IntroducerSummary page 5…Glide Expandable Introducer III. PREDICATE Terumo (formerly Onset Medical Corporation) Solo Path® Balloon Expandable TransFemoral lntroducer (K100819) This predicate has not been subject to a design-related recall. No reference devices were used in this submi… | 2010 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K181817 | transGlideXT Expandable Introducer Class I | 2019 | 0 |
Has anything in its family been recalled? (2 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K100819The Solopath Balloon Expandable Transfemoral IntroducerOnset Medical Corporation · 2010 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall
- K181817transGlideXT Expandable IntroducerTransaortic Medical, Inc. · 2019 · Cites it directly · ◆ in the 2019 descendants bar of FIG. 11 Class I recall
What does this lineage say?
- The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 5.7 years on median.
- 1 of the 2 ancestors has a recall of any class; 1 has a Class I recall.
- Of its descendants, K181817 (Transaortic Medical, Inc., 2019) has gone furthest, with 0 descendants of its own.
- 3 other devices also cite its predicate K100819.
How does its category compare?
All DYB devicesDYB Introducer, Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.
FDA decisions per year · DYB
16in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DYB
63in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DYB
3in 2025
Class I (48 since 2007) Class II/III not classified
Adverse event reports per year · DYB
4,539in 2025
MAUDE reports naming product code DYB, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 12 | 95 | 15 | 316 |
| 2008 | 17 | 37 | 9 | 423 |
| 2009 | 14 | 52 | 25 | 399 |
| 2010 | 18 | 123 | 18 | 445 |
| 2011 | 17 | 100 | 4 | 628 |
| 2012 | 22 | 128 | 3 | 898 |
| 2013 | 26 | 118 | 5 (1) | 743 |
| 2014 | 30 | 122 | 2 | 780 |
| 2015 | 17 | 129 | 2 (1) | 913 |
| 2016 | 19 | 95 | 45 (3) | 1,234 |
| 2017 | 24 | 70 | 22 (1) | 1,672 |
| 2018 | 19 | 156 | 1 | 1,903 |
| 2019 | 18 | 47 | 2 | 2,450 |
| 2020 | 9 | 49 | 21 (21) | 2,465 |
| 2021 | 12 | 78 | 6 | 2,835 |
| 2022 | 13 | 143 | 2 | 4,084 |
| 2023 | 15 | 55 | 10 | 3,775 |
| 2024 | 18 | 56 | 2 | 3,931 |
| 2025 | 16 | 63 | 3 | 4,539 |
| 2026 | 17 | 59 | 23 (21) | — |
What is it indicated for?
The transGlide Expandable Introducer is intended to be inserted into the femoral artery, over a guidewire, and once expanded, to provide a guide for catheters and/or devices introduced into the femoral iliac arteries.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K152194 · printed Nov 6, 2026
Cite this page
510(k) Report. “K152194: transGlide Expandable Introducer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K152194
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026